Plasma ghrelin levels are closely associated with severity and morphology of angiographically-detected coronary atherosclerosis in Chineses patients with diabetes mellitus
- PMID: 22367281
- PMCID: PMC4003365
- DOI: 10.1038/aps.2011.196
Plasma ghrelin levels are closely associated with severity and morphology of angiographically-detected coronary atherosclerosis in Chineses patients with diabetes mellitus
Abstract
Aim: Low plasma ghrelin level was found to be associated with diabetes, and ghrelin was shown to inhibit pro-atherogenic changes in experimental models of atherosclerosis. The aim of this study was to investigate the relationship between plasma ghrelin levels and coronary atherosclerotic lesions in Chinese patients with diabetes.
Methods: Plasma ghrelin levels were measured using an ELISA kit. The severity of coronary artery disease (CAD) was determined via angiography. Composition of atherosclerotic plaques was detected via coronary CT angiography.
Results: A total of 178 patients with diabetes were recruited. Among the patients, 70 were diagnosed with acute coronary syndrome (ACS), 82 with stable angina pectoris (SAP) and 26 without coronary angiographic finding (controls). A negative correlation was found between ghrelin levels and the severity of the CAD, as determined via the Gensini score (r=-0.2434; P=0.0217). In diabetic patients with CAD and a complex lesion, the plasma ghrelin levels were significantly lower than in those with a simple lesion (ACS group: 3.81 ± 0.49 ng/mL vs 4.72 ± 0.50 ng/mL, P<0.0001; SAP group: 4.21 ± 0.52 ng/mL vs 4.76 ± 0.59 ng/mL, P=0.0397). Angiographically-detected complex lesion was an independent factor associated with ghrelin levels (adjusted beta coefficient=-0.67, 95% CI -0.97 to -0.37, P<0.0001).
Conclusion: Low plasma ghrelin level is closely related to angiographically-detected severity and the complex lesion morphology in Chinese diabetic patients with CAD.
Figures



Similar articles
-
Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY.Transl Res. 2010 May;155(5):238-46. doi: 10.1016/j.trsl.2010.01.004. Epub 2010 Feb 21. Transl Res. 2010. PMID: 20403579
-
Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis.Coron Artery Dis. 2020 Nov;31(7):628-635. doi: 10.1097/MCA.0000000000000851. Coron Artery Dis. 2020. PMID: 32040025
-
Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.Clin Biochem. 2013 Oct;46(15):1520-5. doi: 10.1016/j.clinbiochem.2013.06.028. Epub 2013 Jul 11. Clin Biochem. 2013. PMID: 23850850
-
PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography.Clin Biochem. 2019 Dec;74:12-18. doi: 10.1016/j.clinbiochem.2019.09.001. Epub 2019 Sep 4. Clin Biochem. 2019. PMID: 31493378
-
Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.Genet Test Mol Biomarkers. 2015 Oct;19(10):556-60. doi: 10.1089/gtmb.2015.0113. Epub 2015 Aug 11. Genet Test Mol Biomarkers. 2015. PMID: 26263432
Cited by
-
Ghrelin inhibits AngII -induced expression of TNF-α, IL-8, MCP-1 in human umbilical vein endothelial cells.Int J Clin Exp Med. 2015 Jan 15;8(1):579-88. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25785032 Free PMC article.
-
AMPK activity is down-regulated in endothelial cells of GHS-R(-/-) mice.Int J Clin Exp Pathol. 2013 Aug 15;6(9):1770-80. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24040441 Free PMC article.
-
Heal the heart through gut (hormone) ghrelin: a potential player to combat heart failure.Heart Fail Rev. 2021 Mar;26(2):417-435. doi: 10.1007/s10741-020-10032-2. Epub 2020 Oct 6. Heart Fail Rev. 2021. PMID: 33025414 Review.
-
Regional Differences in the Ghrelin-Growth Hormone Secretagogue Receptor Signalling System in Human Heart Disease.CJC Open. 2020 Nov 4;3(2):182-194. doi: 10.1016/j.cjco.2020.10.015. eCollection 2021 Feb. CJC Open. 2020. PMID: 33644732 Free PMC article.
-
Association of the serum apelin, but not ghrelin, with the presence and severity of coronary artery disease.Indian Heart J. 2021 Mar-Apr;73(2):214-217. doi: 10.1016/j.ihj.2021.01.013. Epub 2021 Jan 16. Indian Heart J. 2021. PMID: 33865521 Free PMC article.
References
-
- Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60. - PubMed
-
- Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, et al. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol. 2004;43:165–70. - PubMed
-
- Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun. 2003;310:830–5. - PubMed
-
- Caliskan Y, Gorgulu N, Yelken B, Yazici H, Oflaz H, Elitok A, et al. Plasma ghrelin levels are associated with coronary microvascular and endothelial dysfunction in peritoneal dialysis patients. Ren Fail. 2009;31:807–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous